0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Smallpox FREE

Carolyn J. Hildreth, MD, Writer; Alison E. Burke, MA, Illustrator; Richard M. Glass, MD, Editor
JAMA. 2009;301(10):1086. doi:10.1001/jama.301.10.1086.
Text Size: A A A
Published online

Smallpox is a viral infection caused by the Variola virus (an Orthopoxvirus) that can affect people of all ages. Smallpox is contagious and has a 30% fatality rate. The infection manifests with a fever, which precedes the development of a progressive rash that occurs all over the body starting in the mouth and on the face. The rash appears as firm, fluid-filled, and singularly dimpled bumps that eventually become crusty and then form scabs. The rash can persist for several weeks and leaves pitted scars when the scabs fall off. There is no known treatment for smallpox.

Millions of people died during widespread smallpox epidemics in the past. Fortunately, smallpox was eradicated as a naturally occurring disease in 1980 after a successful worldwide vaccination program. There have been no cases in the United States since 1972. Most persons born before 1971 were vaccinated once against smallpox. Currently there are no recommendations for vaccination of the general public against smallpox, although there is concern that this virus could be used for bioterrorism. The United States has an adequate supply of smallpox vaccine for those who would need it in the event of such an outbreak. This includes all those known to be directly exposed, health care workers, public health workers, and volunteer responders to the crisis situation. The March 11, 2009, issue of JAMA includes an article about smallpox vaccination.

DIAGNOSIS

  • Based on symptoms and appearance of the rash, definitive testing must be done at the Centers for Disease Control and Prevention (CDC) or at a CDC Laboratory Response Network (LRN) designated variola testing laboratory.

  • Testing is done using a tissue sample from the skin of the infected person, taken from one of the rash lesions.

PREVENTION

  • People who have had smallpox and survived are immune (protected against reinfection).

  • Vaccination helps to prevent infection in people who are exposed or at immediate risk of exposure and can be effective even when given 3 to 4 days after exposure.

  • Hospitalization and isolation of the infected person and vaccination of those who have had close direct contact with that person, particularly after the rash began to develop

  • Previous vaccination does not provide lifelong immunity and booster vaccination is necessary for those who may be or have been exposed.

FOR MORE INFORMATION

INFORM YOURSELF

To find this and other JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish.

Source: Centers for Disease Control and Prevention

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

TOPIC: INFECTIOUS DISEASES

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles